Invesco Nasdaq Biotechnology ETF (IBBQ)
22.02
+0.02
(+0.10%)
USD |
NASDAQ |
May 31, 16:00
21.95
-0.07
(-0.33%)
After-Hours: 20:00
IBBQ Total Assets Under Management: 32.32M for May 31, 2024
Total Assets Under Management Chart
Historical Total Assets Under Management Data
Date | Value |
---|---|
May 31, 2024 | 32.32M |
May 30, 2024 | 31.76M |
May 29, 2024 | 32.14M |
May 28, 2024 | 32.56M |
May 24, 2024 | 32.53M |
May 23, 2024 | 32.53M |
May 22, 2024 | 33.09M |
May 21, 2024 | 32.79M |
May 20, 2024 | 32.91M |
May 17, 2024 | 32.87M |
May 16, 2024 | 33.02M |
May 15, 2024 | 32.79M |
May 14, 2024 | 32.27M |
May 13, 2024 | 31.86M |
May 10, 2024 | 32.13M |
May 09, 2024 | 32.03M |
May 08, 2024 | 32.21M |
May 07, 2024 | 32.14M |
May 06, 2024 | 32.21M |
May 03, 2024 | 31.68M |
May 02, 2024 | 31.28M |
May 01, 2024 | 30.62M |
April 30, 2024 | 30.93M |
April 29, 2024 | 30.41M |
April 26, 2024 | 30.14M |
Date | Value |
---|---|
April 25, 2024 | 30.52M |
April 24, 2024 | 30.60M |
April 23, 2024 | 30.21M |
April 22, 2024 | 29.90M |
April 19, 2024 | 29.84M |
April 18, 2024 | 29.93M |
April 17, 2024 | 30.10M |
April 16, 2024 | 30.30M |
April 15, 2024 | 30.30M |
April 12, 2024 | 30.65M |
April 11, 2024 | 31.32M |
April 10, 2024 | 31.13M |
April 09, 2024 | 31.29M |
April 08, 2024 | 31.24M |
April 05, 2024 | 31.05M |
April 04, 2024 | 28.66M |
April 03, 2024 | 28.70M |
April 02, 2024 | 29.33M |
April 01, 2024 | 29.48M |
March 28, 2024 | 29.59M |
March 27, 2024 | 29.14M |
March 26, 2024 | 29.17M |
March 25, 2024 | 29.17M |
March 22, 2024 | 29.39M |
March 21, 2024 | 29.25M |
Total Assets Under Management Definition
Total Assets Under Management (AUM) is the total market value of the investments that a fund holds.
Total Assets Under Management Range, Past 5 Years
12.81M
Minimum
Mar 22 2023
67.16M
Maximum
Jul 07 2021
26.81M
Average
21.97M
Median
Total Assets Under Management Benchmarks
VanEck Biotech ETF | 431.66M |
Global X Aging Population ETF | 60.77M |
Global X Genomics & Biotechnology ETF | 92.72M |
iShares Genomics Immnlgy & Hlthcr ETF | 138.94M |
ProShares Ultra Nasdaq Biotechnology | 88.27M |